Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (311-320 of 862) with videos related to

Pageof 87
Sort By:
The International Journal of Neuropsychopharmacology|January 9, 2015
Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stressChun Yang, Yukihiko Shirayama, Ji-Chun Zhang, et al.
Psychiatry Research|June 22, 2021
Loss of parvalbumin-positive cells in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamineChun Yang, Mei Han, Ji-Chun Zhang, et al.
Artificial Organs|September 30, 2024
Impact of mechanical circulatory support on in-hospital outcomes among patients with ventricular tachycardia requiring ablationKenji Hashimoto, Abdul Rahman Akkawi, Mohamad Ghazal, et al.
Molecular Psychiatry|April 16, 2026
Exploring the lung-brain axis in perioperative neurocognitive disorders: a potential therapeutic targetPenghui Wei, Tong Zhu, Kenji Hashimoto, et al.
Synapse (New York, N.Y.)|September 30, 2003
Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Lee Schechter, Kenji Hashimoto, et al.
The International Journal of Neuropsychopharmacology|September 10, 2016
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress ModelBangkun Yang, Qian Ren, Min Ma, et al.
Brain Research|November 25, 2010
Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in miceYuto Takatsu, Yuko Fujita, Takashi Tsukamoto, et al.
Molecular Psychiatry|April 14, 2026
Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disordersTing-Ting Zhu, Pan-Miao Liu, Kenji Hashimoto, et al.
Psychiatry Research|April 5, 2016
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamineChun Yang, Mei Han, Ji-Chun Zhang, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|December 15, 2015
On Stereo Confidence Measures for Global Methods: Evaluation, New Model and Integration into Occupancy GridsMartim Brandão, Ricardo Ferreira, Kenji Hashimoto, et al.
Pageof 87

Showing results (311-320 of 862) with videos related to

Sort By:
Pageof 87
The International Journal of Neuropsychopharmacology|January 9, 2015
Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stressChun Yang, Yukihiko Shirayama, Ji-Chun Zhang, et al.
Psychiatry Research|June 22, 2021
Loss of parvalbumin-positive cells in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamineChun Yang, Mei Han, Ji-Chun Zhang, et al.
Artificial Organs|September 30, 2024
Impact of mechanical circulatory support on in-hospital outcomes among patients with ventricular tachycardia requiring ablationKenji Hashimoto, Abdul Rahman Akkawi, Mohamad Ghazal, et al.
Molecular Psychiatry|April 16, 2026
Exploring the lung-brain axis in perioperative neurocognitive disorders: a potential therapeutic targetPenghui Wei, Tong Zhu, Kenji Hashimoto, et al.
Synapse (New York, N.Y.)|September 30, 2003
Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Lee Schechter, Kenji Hashimoto, et al.
The International Journal of Neuropsychopharmacology|September 10, 2016
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress ModelBangkun Yang, Qian Ren, Min Ma, et al.
Brain Research|November 25, 2010
Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in miceYuto Takatsu, Yuko Fujita, Takashi Tsukamoto, et al.
Molecular Psychiatry|April 14, 2026
Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disordersTing-Ting Zhu, Pan-Miao Liu, Kenji Hashimoto, et al.
Psychiatry Research|April 5, 2016
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamineChun Yang, Mei Han, Ji-Chun Zhang, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|December 15, 2015
On Stereo Confidence Measures for Global Methods: Evaluation, New Model and Integration into Occupancy GridsMartim Brandão, Ricardo Ferreira, Kenji Hashimoto, et al.
Pageof 87